PKU sphere™ NEXT15
A ready-to-drink low phenylalanine* (Phe) medical food for use in the dietary management of Phenylketonuria (PKU).
PKU sphere™ NEXT15 is suitable for ages 1 year and over.
FOR USE UNDER MEDICAL SUPERVISION.
View full product information (Bottle)
FLAVOURS
To request a sample, speak to your healthcare professional.
FLAVOURS
A ready-to-drink low phenylalanine* (Phe) medical food for use in the dietary management of Phenylketonuria (PKU).
PKU sphere™ NEXT15 is suitable for ages 1 year and over.
FOR USE UNDER MEDICAL SUPERVISION.
View full product information (Bottle)
To request a sample, speak to your healthcare professional.
Features
- Lowest** in sugar and includes beneficial fats increasing calorie content (161 kcal per bottle) and contributing to a mild, creamy taste
- Lowest*** volume RTD GMP formula optimizing intake of protein equivalent (15 g PE in a 180 mL bottle)
- Evidence-based innovation with the same carefully designed1 and clinically evaluated2-4 GMP:AA blendas PKU sphere powder, demonstrating safety, efficacy, growth and metabolic control.
- Contains no artificial sweeteners, flavours, or added colours
- Available in creamy, neutral flavour
*Each 180 mL oz bottle contains 23 mg of phe
**Among the non-Vitaflo GMP RTD formulas for PKU with ≥10 kcal/g PE
***Among the non-Vitaflo GMP RTD formulas for PKU
1. Daly A, et al. Impact of the amino acid profile of casein glycomacropeptide on metabolic control in children with PKU. J Inherit Metab Dis Rep. 2016; 39(Suppl. 1): S85.
2. Daly A, Evans S, Chahal S, et al. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU. Orphanet J Rare Dis. 2019;14(1):44. Published 2019 Feb 15. doi:10.1186/s13023-019-1011-y
3. Daly A, Högler W, Crabtree N, et al. Growth and Body Composition in PKU Children—A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes. Nutrients. 2021;13(4):1323. DOI: 10.3390/nu13041323
4. Daly A, Crabtree N, Shaw N, et al. A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes. Nutrients. 2021;13. doi: 10.3390/nu13062075
Nutrition Information
per 180 mL (1 bottle)
-
161
Calories
-
15 g
Protein Equivalent
-
7.7 g
Carbohydrate
-
7.7 g
Total Fat
-
85 mg
DHA
